Adams J - Search Results

1

CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia.

Rahaman MH, Yu Y, Zhong L, Adams J, Lam F, Li P, Noll B, Milne R, Peng J, Wang S. Rahaman MH, et al. Among authors: adams j. Invest New Drugs. 2019 Aug;37(4):625-635. doi: 10.1007/s10637-018-0661-2. Epub 2018 Sep 8. Invest New Drugs. 2019. PMID: 30194564

2

Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73.

Lam F, Abbas AY, Shao H, Teo T, Adams J, Li P, Bradshaw TD, Fischer PM, Walsby E, Pepper C, Chen Y, Ding J, Wang S. Lam F, et al. Among authors: adams j. Oncotarget. 2014 Sep 15;5(17):7691-704. doi: 10.18632/oncotarget.2296. Oncotarget. 2014. PMID: 25277198 Free PMC article.

3

Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells.

Li P, Diab S, Yu M, Adams J, Islam S, Basnet SK, Albrecht H, Milne R, Wang S. Li P, et al. Among authors: adams j. Oncotarget. 2016 Aug 30;7(35):56811-56825. doi: 10.18632/oncotarget.10796. Oncotarget. 2016. PMID: 27462781 Free PMC article.

4

Targeting CDK9 for treatment of colorectal cancer.

Rahaman MH, Lam F, Zhong L, Teo T, Adams J, Yu M, Milne RW, Pepper C, Lokman NA, Ricciardelli C, Oehler MK, Wang S. Rahaman MH, et al. Among authors: adams j. Mol Oncol. 2019 Oct;13(10):2178-2193. doi: 10.1002/1878-0261.12559. Epub 2019 Aug 21. Mol Oncol. 2019. PMID: 31398271 Free PMC article.

5

Discovery of (E)-3-((styrylsulfonyl)methyl)pyridine and (E)-2-((styrylsulfonyl)methyl)pyridine derivatives as anticancer agents: synthesis, structure-activity relationships, and biological activities.

Lu T, Goh AW, Yu M, Adams J, Lam F, Teo T, Li P, Noll B, Zhong L, Diab S, Chahrour O, Hu A, Abbas AY, Liu X, Huang S, Sumby CJ, Milne R, Midgley C, Wang S. Lu T, et al. Among authors: adams j. J Med Chem. 2014 Mar 27;57(6):2275-91. doi: 10.1021/jm4019614. Epub 2014 Mar 10. J Med Chem. 2014. PMID: 24471873

6

Targeting Pim kinases for cancer treatment: opportunities and challenges.

Le BT, Kumarasiri M, Adams JR, Yu M, Milne R, Sykes MJ, Wang S. Le BT, et al. Among authors: adams jr. Future Med Chem. 2015;7(1):35-53. doi: 10.4155/fmc.14.145. Future Med Chem. 2015. PMID: 25582332 Review.

7

LTBP-2 Has a Single High-Affinity Binding Site for FGF-2 and Blocks FGF-2-Induced Cell Proliferation.

Menz C, Parsi MK, Adams JR, Sideek MA, Kopecki Z, Cowin AJ, Gibson MA. Menz C, et al. Among authors: adams jr. PLoS One. 2015 Aug 11;10(8):e0135577. doi: 10.1371/journal.pone.0135577. eCollection 2015. PLoS One. 2015. PMID: 26263555 Free PMC article.

8

LTBP-2 has multiple heparin/heparan sulfate binding sites.

Parsi MK, Adams JR, Whitelock J, Gibson MA. Parsi MK, et al. Among authors: adams jr. Matrix Biol. 2010 Jun;29(5):393-401. doi: 10.1016/j.matbio.2010.03.005. Epub 2010 Apr 9. Matrix Biol. 2010. PMID: 20382221

9

A Central Bioactive Region of LTBP-2 Stimulates the Expression of TGF-β1 in Fibroblasts via Akt and p38 Signalling Pathways.

Sideek MA, Smith J, Menz C, Adams JRJ, Cowin AJ, Gibson MA. Sideek MA, et al. Among authors: adams jrj. Int J Mol Sci. 2017 Oct 9;18(10):2114. doi: 10.3390/ijms18102114. Int J Mol Sci. 2017. PMID: 28991210 Free PMC article.

10

Molecular characterization and analysis of the acrB gene of Aspergillus nidulans: a gene identified by genetic interaction as a component of the regulatory network that includes the CreB deubiquitination enzyme.

Boase NA, Lockington RA, Adams JR, Rodbourn L, Kelly JM. Boase NA, et al. Among authors: adams jr. Genetics. 2003 May;164(1):95-104. doi: 10.1093/genetics/164.1.95. Genetics. 2003. PMID: 12750323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,992 results

Search Page

Filters